Clinical Trials Search

Title Intervention Sponsor Status
Mobile Health for Adherence in Breast Cancer Patients Electronic Health Record Review, Health Promotion and Education, Health Telemonitoring, Interview, Patient Navigation, Survey Administration, Text Message-Based Navigation Intervention ECOG-ACRIN Cancer Research Group Recruiting
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States Electronic Health Record Review, Interview, Survey Administration Children's Oncology Group Recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid National Cancer Institute (NCI) Active, not recruiting
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer Endocrine therapy interruption ETOP IBCSG Partners Foundation Active, not recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery Endoxifen Hydrochloride, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Active, not recruiting
Informational Meetings for Planning and Coordinating Treatment Enhanced Usual Care Parent Education, Novel Communication Intervention Indiana University Recruiting
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment Enhanced Usual Care, Pathways Laurie McLouth Recruiting
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors Entecavir, Tenofovir Disoproxil Fumarate, Best Practice, Tenofovir Alafenamide SWOG Cancer Research Network Active, not recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer Exemestane, Laboratory Biomarker Analysis, Pharmacokinetic Study, Questionnaire Administration National Cancer Institute (NCI) Active, not recruiting
Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer Extended Release Metformin Hydrochloride, Biopsy, Biospecimen Collection, Bronchoscopy, Questionnaire Administration National Cancer Institute (NCI) Recruiting